TargetMol

Deamino-hydroxytamoxifen

Product Code:
 
TAR-T31262
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T31262-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31262-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31262-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Tamoxifen is a medication that is used to prevent breast cancer patients.
CAS:
77207-49-9
Formula:
C24H24O2
Molecular Weight:
344.454
Purity:
0.98
SMILES:
CCC(=C(/c1ccccc1)c1ccc(OCCO)cc1)c1ccccc1

References

1. Fried KM, Wainer IW. Direct determination of tamoxifen and its four major metabolites in plasma using coupled column high-performance liquid chromatography. J Chromatogr B Biomed Appl. 1994 May 13;655(2):261-8. PubMed PMID: 8081472. 2. Langan-Fahey SM, Tormey DC, Jordan VC. Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer. Eur J Cancer. 1990;26(8):883-8. PubMed PMID: 2145931. 3. Etienne MC, Milano G, Fischel JL, Frenay M, Fran?ois E, Formento JL, Gioanni J, Namer M. Tamoxifen metabolism: pharmacokinetic and in vitro study. Br J Cancer. 1989 Jul;60(1):30-5. PubMed PMID: 2803912; PubMed Central PMCID: PMC2247345. 4. Milano G, Etienne MC, Frenay M, Khater R, Formento JL, Renee N, Moll JL, Francoual M, Berto M, Namer M. Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours. Br J Cancer. 1987 May;55(5):509-12. PubMed PMID: 3606944; PubMed Central PMCID: PMC2001713.